Synergistic actions of insulin-sensitive and Sirt1-mediated pathways in the differentiation of mouse embryonic stem cells to osteoblast

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 153-164

  Srivastava, Swati ^a   Bedi, Upasana ^a,b   Roy, Partha ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adipocytes; Akt; Differentiation; Insulin; Osteoblast; Sirt1

Indexed keywords

ALKALINE PHOSPHATASE; INSULIN; MESSENGER RNA; PROTEIN KINASE B; SIRTUIN 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE; GENE EXPRESSION; MARKER GENE; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOGENIC GENE; OSTEOPONTIN GENE; OSTEOPROTEGERIN GENE; OSTERIX GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; RUNX2 GENE;

ADIPOCYTES; ANIMALS; BETA CATENIN; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE SILENCING; INSULIN; LIPID METABOLISM; MICE; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; TRANSCRIPTION, GENETIC;

EID: 84864334969     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.04.002     Document Type: Article

References (48)

1. Aleckovic M., Simon C. Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?. Reprod. Biomed. Online 2008, 17:270-280.
2. Backesjo C.M., et al. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J. Bone Miner. Res. 2006, 21:993-1002.
3. Burkhardt R., et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987, 8:157-164.
4. Calvanese V., et al. Sirtuin1 regulation of developmental genes during differentiation of stem cells. Proc. Natl. Acad. Sci. USA 2010, 107(31):13736-13741.
5. Camins A., et al. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Finds Exp. Clin. Pharmacol. 2008, 30:43-65.
6. Cheng H.L., et al. Developmental defects and p53 hyperacetylation is sir2 homolog (Sirt1) deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100(19):10794-10799.
7. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
8. Coussens M., et al. Sirt1 deficiency attenuates spermatogenesis and germ cell function. PloS One 2008, 3:e1571.
9. Davies P.S.W., Cole T.J. Body composition techniques in health and disease 1995, Cambridge University Press, UK. first ed.
10. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4:263-273.
11. Fulco M., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 2008, 14:661-673.
12. Fulzele K., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142(2):309-319.
13. Gao Y., et al. Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. J. Pharm. Pharmacol. 2008, 60(12):1695-1700.
14. Guller S., et al. Role of insulin in growth hormone-stimulated 3T3 cell adipogenesis. Endocrinology 1988, 122(5):2084-2089.
15. Hole N., Smith A.G. Embryonic stem cell and hematopoiesis. Culture of Hematopoetic Cells 1994, 235-249. Wiley-Liss, New York. R.I. Freshney, I.B. Pragnell, M.G. Freshney (Eds.).
16. Janghorbani M., et al. Prospective study of diabetes and risk of hip fracture: the nurses' health study. Diabetes Care 2006, 29:1573-1578.
17. Jayme L., et al. Wortmannin-sensitive trafficking pathways in chinese hamster ovary cells. J. Biol. Chem. 1996, 271(18):10953-10962.
18. Kemink S.A., et al. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Invest. 2000, 23:295-303.
19. Kenner K.A., et al. Protein tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J. Biol. Chem. 1996, 271:19810-19816.
20. Klemm D.J., et al. Insulin-induced adipocyte differentiation. J. Biol. Chem. 2001, 276(30):28430-28435.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
22. Li H.X., et al. Roles of Wnt/β- catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells. Mol. Cell. Endocrinol. 2008, 291:116-124.
23. Magun R., et al. Expression of a constitutively activated form of protein kinase B (c- Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 1996, 137:3590-3593.
24. McBurney, et al. The mammalian SIR2 alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 2003, 23(1):38-54.
25. McCarty M.F. Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. Med. Hypotheses 1995, 45(3):241-246.
26. Meunier P., et al. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 1971, 80:147-154.
27. Megam M., et al. Geranylgeranylpyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation. Bone 2011, 10.1016/j.bone.2011.09.056.
28. Mishima N., et al. Effect of streptozotocin induced diabetes mellitus on alveolar bone deposition in the rat. Arch. Oral Biol. 2002, 47:843-849.
29. Nuttall M.E., et al. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J. Bone Miner. Res. 1998, 13:371-382.
30. Okazaki R., et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β. Endocrinology 2002, 143(6):2349-2356.
31. Park S.R., et al. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 1999, 24:549-554.
32. Picard F., et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPARγ. Nature 2004, 429:771-776.
33. Prozorovski T., et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat. Cell Biol. 2008, 10:385-394.
34. Pun K.K., et al. The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J. Bone Miner. Res. 1989, 4:853-862.
35. Raucci A., et al. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell Physiol. 2008, 215(2):442-451.
36. Rathjen J., Rathjen P.D. Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr. Opin. Genet. Dev. 2000, 11:587-594.
37. Rieusset J., et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor in human adipocytes. Diabetes 1999, 48:699-705.
38. Robertson B.W., Chellaiah M.A. Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cells. Exp. Cell Res. 2010, 316:1-11.
39. Sang W.K., et al. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem. Biophys. Res. Commun. 2005, 327:811-819.
40. Santos A., et al. Early activation of the β-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidylinositol-3kinase/Akt, and focal adhesion kinase. Biochem. Biophys. Res. Commun. 2010, 391:364-369.
41. Shandala T. Potential role of protein deacetylase Sirt1 in methotrexate chemotherapy-induced bone and bone marrow damage. Bone 2009, 44:S166.
42. Sun C., et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007, 6:307-319.
43. Thrailkill K.M. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol. Ther. 2000, 2:69-80.
44. Van Ginkel P.R., et al. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin. Cancer Res. 2007, 13:5162-5169.
45. Xie Y.B. Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor γ transactivation. J. Biol. Chem. 2009, 284(42):28762-28774.
46. Yang J., et al. Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells. Cell Biochem. Funct. 2010, 28:334-341.
47. Zhang J. The direct involvement of Sirt1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 2007, 282(47):34356-34364.
48. Zhou H., et al. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp. Cell Res. 2009, 315(17):2953-2962.